## Abstract ## BACKGROUND: The purpose of the study was to identify predictors of weight loss during radiotherapy (RT) in patients with stage I or II head and neck (HN) cancer. ## METHODS: This study was conducted as part of a phase 3 chemoprevention trial. A total of 540 patients were randomize
Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer
β Scribed by Aleksandar F. Dragovic; James A. Bonner; Sharon A. Spencer; Lisle M. Nabell; William R. Carroll; Jimmy J. Caudell
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 196 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
Altered fractionated radiotherapy (RT) has been shown to improve locoregional control (LRC) and overall survival (OS) in squamous cell cancer of the head and neck (SCCHN). We investigated patient outcomes using a new parameter: the average weekly dose (AWD).
Methods
The medical records of 601 patients who received definitive RT for SCCHN were reviewed. AWD was calculated by dividing the total dose in Gray (Gy) by overall treatment time in weeks, and assessed for predictive value.
Results
Various standard RT fractionation schedules were used. An AWD >10.0 Gy was associated with improved LRC at 2 years for patients treated with RT alone (80.9% vs 60.9%; p = .006), but not for those treated with concurrent chemoradiation (75.3% vs 77.3%; p = .77). Nonsignificant increases in late dysphagia were seen with AWD >10.0 Gy.
Conclusion
An AWD of >10 Gy was found to be beneficial for RT alone regimens but not chemoradiotherapy regimens. Head Neck, 2011
π SIMILAR VOLUMES
## Abstract ## Background. The impact of posttreatment neck dissection on prolonged feeding tube dependence in patients with head and neck squamous cell cancer (HNSCC) treated with primary radiation or chemoradiation remains unknown. ## Methods. We conducted a retrospective cohort study using pr
## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##
## Abstract ## BACKGROUND. The risk, severity, and patientβreported outcomes of radiationβinduced mucositis among head and neck cancer patients were prospectively estimated. ## METHODS. A validated, patientβreported questionnaire (OMDQ), the FACT quality of life (QOL), and the Functional Assessm
## Background: The aim was to evaluate the relationship between nutrition support (ns) on host toxicity and cancer outcome in patients with locally advanced head and neck squamous cell carcinoma (hnscc) undergoing definitive radiotherapy (xrt). ## Methods: We performed a secondary analysis of rad